艾吉纳斯(AGEN)02-27 05:35
$艾吉纳斯(AGEN)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-046230 Act: 34 Size: 459 KB 网页链接查看全文
艾吉纳斯(AGEN)03-15 05:35
$艾吉纳斯(AGEN)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-24-068058 Act: 33 Size: 490 KB 网页链接查看全文
艾吉纳斯(AGEN)04-23 04:15
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046417 Size: 5 KB 网页链接查看全文
艾吉纳斯(AGEN)04-23 04:15
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046416 Size: 5 KB 网页链接查看全文
艾吉纳斯(AGEN)04-02 05:15
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-039491 Size: 5 KB 网页链接查看全文
艾吉纳斯(AGEN)04-09 03:05
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042533 Size: 7 KB 网页链接查看全文
艾吉纳斯(AGEN)02-14 06:05
$艾吉纳斯(AGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020199 Act: 34 Size: 13 KB 网页链接查看全文
知行合一50901-13 16:01
回复@半拉洋芋: 下一个起跳大涨的会是艾吉纳斯吗//@半拉洋芋:回复@生生不息之2000:有关系的4家公司,3家牛气冲天,也不知道是不是沾美股的光。 查看图片查看全文
chuminhua2023-08-24 23:14
8/23,Agenus $安帝君斯(AGEN)$ 周三宣布计划裁员 25%,因为这家免疫肿瘤公司将注意力集中在其针对多种癌症的领先的 botensilimab/balstilimab (BOT/BAL) 项目上。 消息传出后,公司股价下跌约 7%。
根据新安排,预计到今年年底将节省约 4000 万美元,Agenus 表示将暂时推迟所有与 BOT/BAL 无...查看全文
424B3 - Prospectus [Rule 424(b)(3)] Filed: 2011-05-05 AccNo: 0001193125-11-127379 Size: 794 KB 网页链接
424B3 - Prospectus [Rule 424(b)(3)] Filed: 2011-05-05 AccNo: 0001193125-11-127381 Size: 794 KB 网页链接
424B3 - Prospectus [Rule 424(b)(3)] Filed: 2011-05-05 AccNo: 0001193125-11-127379 Size: 794 KB 网页链接
424B3 - Prospectus [Rule 424(b)(3)] Filed: 2011-05-05 AccNo: 0001193125-11-127382 Size: 793 KB 网页链接
424B3 - Prospectus [Rule 424(b)(3)] Filed: 2011-05-05 AccNo: 0001193125-11-127381 Size: 794 KB 网页链接
424B3 - Prospectus [Rule 424(b)(3)] Filed: 2011-05-05 AccNo: 0001193125-11-127382 Size: 793 KB 网页链接
DEF 14A - Other definitive proxy statements Filed: 2011-05-03 AccNo: 0001193125-11-123742 Size: 787 KB 网页链接
8-K - Current report Filed: 2011-04-28 AccNo: 0001171843-11-001163 Size: 31 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046416 Size: 5 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046419 Size: 5 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046420 Size: 5 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046418 Size: 5 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046417 Size: 5 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046294 Size: 7 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042533 Size: 7 KB 网页链接
$艾吉纳斯(AGEN)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001193125-24-088492 Act: 34 Size: 164 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-039491 Size: 5 KB 网页链接
$艾吉纳斯(AGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-039351 Size: 5 KB 网页链接